Actinium CSO reports 213,648 RSUs, 120K options
CSO Kamal Adeela reports initial holdings in ATNM, including time-vested RSUs and long-dated stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Actinium Pharmaceuticals, Inc. (ATNM) reported the initial equity holdings of Chief Scientific Officer Kamal Adeela. The filing lists 213,648 shares of Common Stock in the form of restricted stock units and stock options over 120,000 shares of Common Stock.
Of the restricted stock units, 80,000 vest in three equal installments on September 2, 2027, September 2, 2028 and September 2, 2029, and 133,648 vest on September 2, 2029. The stock options have an exercise price of $1.00 per share, vest in fifty equal monthly tranches beginning on October 2, 2026, and expire on September 2, 2036.
Insider Trade Summary
Holdings reported, no transactions
Holdings
Insider
Kamal Adeela
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| Holding | Common Stock F1 | -- | -- | -- |
Holdings:
Stock Option (Right to Buy) — 120,000 contracts (Direct);
Common Stock — 213,648 shares (Direct)
Footnotes (2)
- F1. Represents restricted stock units ("RSUs"). 80,000 of the RSUs vest as follows: 1/3 on September 2, 2027, 1/3 on September 2, 2028, and 1/3 on September 2, 2029. 133,648 of the RSUs vest on September 2, 2029.
- F2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on October 2, 2026.
Key Figures
Restricted stock units: 213,648 shares
RSUs vesting in three installments: 80,000 shares
RSUs vesting on a single date: 133,648 shares
+4 more
7 metrics
Restricted stock units
213,648 shares
Total restricted stock units reported as Common Stock holdings
RSUs vesting in three installments
80,000 shares
Vesting 1/3 on September 2, 2027, 1/3 on September 2, 2028, 1/3 on September 2, 2029
RSUs vesting on a single date
133,648 shares
Restricted stock units vesting on September 2, 2029
Stock option underlying shares
120,000 shares
Underlying common shares subject to reported stock options
Option exercise price
$1.00 per share
Exercise price of stock options over 120,000 shares
Option expiration date
September 2, 2036
Expiration date of the reported stock options
Option vesting tranches
50 monthly tranches
Vesting begins on October 2, 2026 in fifty equal monthly tranches
Key Terms
restricted stock units, RSUs, stock options, vest
4 terms
restricted stock units financial
"Represents restricted stock units ("RSUs"). 80,000 of the RSUs vest as follows"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Represents restricted stock units ("RSUs"). 80,000 of the RSUs vest as follows"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
stock options financial
"The stock options vest and become exercisable in fifty equal monthly tranches"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vest financial
"80,000 of the RSUs vest as follows: 1/3 on September 2, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the ATNM Form 3 disclose about Kamal Adeela's equity holdings?
The Form 3 discloses that Chief Scientific Officer Kamal Adeela holds 213,648 restricted stock units and stock options over 120,000 shares of Actinium Pharmaceuticals, Inc. common stock, subject to specified vesting schedules and an option exercise price of $1.00 per share.
How many ATNM restricted stock units does Kamal Adeela hold and how do they vest?
Kamal Adeela holds 213,648 restricted stock units. 80,000 vest in three equal installments on September 2, 2027, September 2, 2028 and September 2, 2029, and 133,648 vest on September 2, 2029, as disclosed in the filing’s footnote.
What stock options in ATNM does Kamal Adeela report on the Form 3?
The Form 3 reports stock options giving Kamal Adeela the right to acquire 120,000 shares of Actinium Pharmaceuticals, Inc. common stock at an exercise price of $1.00 per share, with an expiration date of September 2, 2036.
What is the vesting schedule for Kamal Adeela’s ATNM stock options?
The filing states that Kamal Adeela’s stock options vest and become exercisable in fifty equal monthly tranches beginning on October 2, 2026. These options relate to 120,000 underlying shares of Actinium Pharmaceuticals, Inc. common stock.
Are there any stock sales or purchases reported in Kamal Adeela’s ATNM Form 3?
No stock sales or purchases are reported. The Form 3 is an initial statement of beneficial ownership and lists holdings in restricted stock units and stock options, without reporting any buy or sell transactions in Actinium Pharmaceuticals, Inc. common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
